SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-134421
Filing Date
2023-05-03
Accepted
2023-05-03 16:17:02
Documents
12
Period of Report
2023-04-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d238325d8k.htm   iXBRL 8-K 23146
  Complete submission text file 0001193125-23-134421.txt   147897

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atnx-20230427.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20230427_lab.xml EX-101.LAB 18705
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20230427_pre.xml EX-101.PRE 11695
6 EXTRACTED XBRL INSTANCE DOCUMENT d238325d8k_htm.xml XML 3528
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 23884215
SIC: 2834 Pharmaceutical Preparations